Allovir (KLRS) Stock Chart & Stock Price History $2.92 -0.04 (-1.35%) As of 05/30/2025 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock Allovir Stock Price Performance The Allovir (KLRS) stock chart highlights key performance trends across multiple timeframes. As of the latest close, Allovir traded at $2.92 with a market cap of $54.61 million and volume of 16,200 shares. Receive KLRS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Allovir and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+4.66% KLRS Stock Chart for Saturday, May, 31, 2025 KLRS Chart by TradingView Allovir Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/30/2025$2.96$2.92-1.35%$3.10$2.8816,200 shs$54.61 million05/29/2025$2.90$2.96+2.07%$3.04$2.8018,214 shs$55.36 million05/28/2025$2.91$2.90-0.34%$3.04$2.8116,357 shs$54.24 million05/27/2025$2.79$2.91+4.30%$2.94$2.7939,617 shs$54.42 million05/26/2025$2.79$2.79$2.87$2.65119,062 shs$52.18 million Related Companies ATNFW Stock Chart LBPSW Stock Chart AEHAW Stock Chart AIMDW Stock Chart ALVOW Stock Chart ACABW Stock Chart BFRIW Stock Chart BTMDW Stock Chart BCTXW Stock Chart CELUW Stock Chart Receive KLRS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Allovir and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:KLRS) was last updated on 5/31/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredAs Bitcoin supply vanishes, this Trump-aligned token could explodeBitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Allovir, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Allovir With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
